Influenza A (H1N1) Vaccines-monitoring safety profile

With the initiation of H1N1 vaccination, the Pharmacovigilance Branch, HSA is providing additional information on the procedures to monitor the safety profile of the H1N1 influenza vaccines. MOH and HSA will be intensifying our efforts to closely monitor the safety and usage of H1N1 vaccines in our local population. Therefore, healthcare professionals are required to

  • notify the National Immunization Registry (NIR) of all patients who have been vaccinated with H1N1 vaccines
  • report all suspected serious vaccine adverse events (VAE) to HSA. 

The information provided by healthcare professionals will allow HSA to accurately compute the incidence rate of vaccine adverse events in Singapore and also potentially help determine whether any specific patient groups may be at a higher risk of serious adverse events.

Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.